{"docs": [{"idx": "chunk-2aa47410274741a948cf8a94b0e3d88e", "passage": "Thomas C. Sudhof\nIntroduction\nThomas Christian Sudhof (German pronunciation: ['to:mas 'zy:t,ho:f] i; born December 22, 1955), ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.", "extracted_entities": ["Thomas C. Sudhof", "Thomas Christian Sudhof", "December 22, 1955", "ForMemRS", "German-American", "Stanford University"], "extracted_triples": [["Thomas C. Sudhof", "is", "German-American biochemist"], ["Thomas C. Sudhof", "born on", "December 22, 1955"], ["Thomas C. Sudhof", "known for", "study of synaptic transmission"], ["Thomas C. Sudhof", "is a professor in", "school of medicine"], ["Thomas C. Sudhof", "works in", "department of molecular and cellular physiology"], ["Thomas C. Sudhof", "has courtesy appointment in", "neurology"], ["Thomas C. Sudhof", "has courtesy appointment in", "psychiatry and behavioral sciences"], ["Thomas C. Sudhof", "teaches at", "Stanford University"]]}, {"idx": "chunk-c16ea0604337d62567d52c565ddbeb9a", "passage": "David Eagleman\nIntroduction\nDavid Eagleman (born April 25, 1971) is an American neuroscientist, author, and science communicator. He teaches neuroscience at Stanford University[1] and is CEO and co-founder of Neosensory, a company that develops devices for sensory substitution. [2] He also directs the non-profit Center for Science and Law, which seeks to align the legal system with modern neuroscience[3] and is Chief Science Officer and co-founder of BrainCheck, a digital cognitive health platform used in medical practices and health systems.", "extracted_entities": ["David Eagleman", "April 25, 1971", "American", "Stanford University", "Neosensory", "Center for Science and Law", "BrainCheck"], "extracted_triples": [["David Eagleman", "was born on", "April 25, 1971"], ["David Eagleman", "is", "American neuroscientist"], ["David Eagleman", "teaches", "neuroscience"], ["David Eagleman", "teaches at", "Stanford University"], ["David Eagleman", "is CEO and co-founder of", "Neosensory"], ["Neosensory", "develops", "devices for sensory substitution"], ["David Eagleman", "directs", "Center for Science and Law"], ["Center for Science and Law", "seeks to align", "legal system with modern neuroscience"], ["David Eagleman", "is Chief Science Officer and co-founder of", "BrainCheck"], ["BrainCheck", "is", "digital cognitive health platform"], ["BrainCheck", "is used in", "medical practices and health systems"]]}, {"idx": "chunk-1c80787156e4045784b6de4b5ae41ce6", "passage": "Karl Deisseroth\nIntroduction\nKarl Alexander Deisseroth (born November 18, 1971) is an American scientist. He is the D.H. Chen Foundation Professor of Bioengineering and of psychiatry and behavioral sciences at Stanford University. He is known for creating and developing the technologies of hydrogel-tissue chemistry (e.g., CLARITY, STARmap) and optogenetics, and for applying integrated optical and genetic strategies to study normal neural circuit function, as well as dysfunction in neurological and psychiatric disease.", "extracted_entities": ["Karl Deisseroth", "November 18, 1971", "American", "D.H. Chen Foundation", "Stanford University", "CLARITY", "STARmap"], "extracted_triples": [["Karl Deisseroth", "was born on", "November 18, 1971"], ["Karl Deisseroth", "is", "American scientist"], ["Karl Deisseroth", "is the", "D.H. Chen Foundation Professor of Bioengineering"], ["Karl Deisseroth", "is the", "Professor of psychiatry and behavioral sciences"], ["Karl Deisseroth", "works at", "Stanford University"], ["Karl Deisseroth", "is known for", "creating hydrogel-tissue chemistry"], ["Karl Deisseroth", "developed", "CLARITY"], ["Karl Deisseroth", "developed", "STARmap"], ["Karl Deisseroth", "applies", "optogenetics"], ["Karl Deisseroth", "studies", "normal neural circuit function"], ["Karl Deisseroth", "studies", "dysfunction in neurological disease"], ["Karl Deisseroth", "studies", "dysfunction in psychiatric disease"]]}], "avg_ent_chars": 14.6, "avg_ent_words": 2.05}